Study of Genetic Polymorphisms of CYP 3A and MDR-1 Genes in Thai HIV-1 Infected Patients on Saquinavir/Ritonavir.

Trial Profile

Study of Genetic Polymorphisms of CYP 3A and MDR-1 Genes in Thai HIV-1 Infected Patients on Saquinavir/Ritonavir.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Apr 2012

At a glance

  • Drugs Ritonavir; Saquinavir
  • Indications HIV-1 infections
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 05 May 2009 Actual patient number (250) added as reported by ClinicalTrials.gov.
    • 05 May 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 05 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top